CorVel Corporation — Form 10-Q Summary
Period clarification: The filing covers the three months ended June 30, 2012, CorVel’s fiscal first quarter of fiscal 2013. This differs from the request metadata’s “2011 Q1.” The comparable quarter is the three months ended June 30, 2011.
Business context and reporting period
CorVel provides medical cost-containment and managed-care services, principally for workers’ compensation and auto claims. Its services are reported in one operating segment. The unaudited interim results are not necessarily indicative of full-year results.
Key financial metrics
| Metric | Q1 FY2013 | Q1 FY2012 | Change |
|---|---|---|---|
| Revenue | $104.6 million | $102.3 million | +2.2% |
| Gross profit / margin | $23.2 million / 22.2% | $25.5 million / 25.0% | Profit down 9.2% |
| Income before tax | $11.0 million | $13.2 million | −16.9% |
| Net income | $6.6 million | $8.2 million | −19.5% |
| Diluted EPS | $0.58 | $0.70 | −17.1% |
| Operating cash flow | $13.5 million | $15.2 million | Down $1.7 million |
| Capital expenditures | $3.4 million | $7.0 million | Down $3.6 million |
Patient management revenue rose 9.0% to $52.6 million, while network solutions revenue declined 3.8% to $52.0 million. Patient management represented 50.3% of revenue, versus 47.2% a year earlier. Net margin was approximately 6.3%, compared with 8.0%.
At June 30, 2012, cash and cash equivalents were $14.6 million, current assets $84.1 million, and current liabilities $41.7 million; working capital was $42.4 million. The current ratio was approximately 2.0. The company had no debt outstanding. Its revolving credit facility provides up to $10 million and expires in September 2012; $8.0 million of letters of credit were issued separately and do not reduce borrowing availability.
Material changes and management commentary
- Revenue growth was modest and reflected higher patient management services to existing TPA customers, partly offset by lower network solutions revenue. Network solutions volume shifted toward lower-priced services and away from higher-priced services.
- Cost of revenues increased 6.1%, outpacing revenue growth. Management cited a less favorable service mix, higher direct salaries and pharmacy costs, and increased employee health-benefit costs. Gross margin consequently narrowed.
- General and administrative expense declined 1.0% as non-systems costs were managed, partly offset by higher systems costs, including software amortization, support, and maintenance.
- Cash from operations decreased mainly because net income fell. Cash used for equipment purchases also declined, which management attributed primarily to reduced software development activity and capitalization.
- Share repurchases totaled $3.7 million for 86,612 shares during the quarter. Management said it may use cash for further repurchases.
Outlook, risks, and contingencies
No specific revenue or earnings guidance was provided. Management stated that cash and expected internally generated funds should be sufficient for obligations and expected cash needs for at least the next 12 months, and expected to renew the credit line when it expires in September 2012. These are forward-looking statements, not guarantees.
Risks highlighted include competition and pricing pressure, declining workers’ compensation claims, customer insourcing or contract terminations, regulatory changes, labor and benefit costs, litigation exposure, and dependence on reliable systems, data security, and software development. Management reported no goodwill or long-lived-asset impairment at June 30, 2012. Operating lease commitments totaled $47.4 million; uncertain tax positions were $1.0 million.
The Louisiana class action settlement was finally approved and became final in January 2012; CorVel had previously paid $9 million into escrow, following a $9 million pre-tax charge in the March 2011 quarter. The Illinois class settlement had been approved, and final payments were sent July 16, 2012. Management said other ordinary-course litigation was not expected to result in material aggregate payments. Subsequent to quarter-end, CorVel repurchased 9,818 shares for $445,000.
Most important facts to verify
- Confirm the requested period: the filing is for the quarter ended June 30, 2012, not 2011.
- Assess whether the lower-margin service mix and rising direct labor, pharmacy, and benefit costs continue to pressure gross margin.
- Track renewal of the $10 million credit facility, which was due to expire in September 2012.
- Review cash generation, capital spending, and the pace and price of ongoing share repurchases.
- Monitor remaining litigation and regulatory exposure, and confirm completion of the Illinois settlement reporting process.